CDTX NASDAQ
Cidara Therapeutics, Inc.
1W: +0.0%
1M: +0.5%
3M: +129.3%
1Y: +832.4%
3Y: +1525.4%
5Y: +423.4%
$221.38
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$215M
+220.4% ▲
5Y CAGR: +25.5%
Total Liabilities
$51M
-31.6% ▼
5Y CAGR: +10.6%
Shareholders Equity
$163M
+2089.1% ▲
5Y CAGR: +34.0%
Cash & Investments
$190M
+430.6% ▲
5Y CAGR: +30.4%
Total Debt
$4M
-26.7% ▼
5Y CAGR: -21.1%
Net Debt
-$186M
-502.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $36M | $62M | $33M | $36M | $190M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $36M | $62M | $33M | $36M | $190M |
| Net Receivables | $11M | $5M | $6M | $16M | $2M |
| Inventory | $0 | -$3M | $0 | $6M | $0 |
| Other Current Assets | $7M | $3M | $0 | $3M | $19M |
| Total Current Assets | $57M | $72M | $45M | $61M | $211M |
| Property, Plant & Equip. | $1M | $3M | $1M | $5M | $4M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $2M | $533K | $1M | $1M | $96K |
| Total Non-Current Assets | $3M | $4M | $2M | $6M | $4M |
| Total Assets | $60M | $75M | $47M | $67M | $215M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $1M | $1M | $4M | $4M |
| Short-Term Debt | $7M | $3M | $0 | $0 | $0 |
| Deferred Revenue | $14M | $14M | $15M | $25M | $0 |
| Other Current Liabilities | $4M | $10M | $5M | $32M | $44M |
| Total Current Liabilities | $39M | $34M | $41M | $67M | $50M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $11M | $20M | $21M | $8M | $2M |
| Total Liabilities | $50M | $54M | $62M | $75M | $51M |
| — Equity — | |||||
| Common Stock | $4K | $7K | $7K | $9K | $1K |
| Retained Earnings | -$335M | -$377M | -$418M | -$441M | -$611M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $11M | $22M | -$14M | -$8M | $163M |
| Total Liabilities & Equity | $60M | $75M | $47M | $67M | $215M |
| — Key Metrics — | |||||
| Total Debt | $8M | $5M | $1M | $5M | $4M |
| Net Debt | -$28M | -$57M | -$32M | -$31M | -$186M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |